Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
06/11/2003 | EP0973741B1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
06/11/2003 | EP0950053B1 New derivatives of benzoylalkyl-1,2,3,6-tetrahydropyridins |
06/11/2003 | CN1423647A Beta-alanine derivatives and their use as receptor antagonists |
06/11/2003 | CN1423641A Quaternary salts of N-substituted cyclic or acyclic amines as pharmaceuticals |
06/11/2003 | CN1423630A Quaternary ammonium compounds and their use as anti-tussive agents |
06/11/2003 | CN1422852A Substituted hexa azacylo compounds and their use as neuroregulator |
06/11/2003 | CN1111157C Preparation of 2,2,6,6-tetraalkyl-4-piperylhydrazines |
06/10/2003 | US6576791 Local anesthetic compounds and uses |
06/10/2003 | US6576670 Administering 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one-ortho-2 -(dimethylaminoethyl)-oxime or its hemi-fumerate salt |
06/10/2003 | US6576650 No central nervous system side effects |
06/10/2003 | US6576646 Administering cholinesterase inhibitor |
06/10/2003 | US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
06/10/2003 | CA2040489C 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments |
06/05/2003 | WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
06/05/2003 | WO2003045942A2 Chemokine receptor antagonists and methods of use thereof |
06/05/2003 | WO2003045937A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor |
06/05/2003 | WO2003045919A2 Process for the synthesis of amine ethers from secondary amino oxides and uses |
06/05/2003 | WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
06/05/2003 | WO2003045917A2 Ccr-3 receptor antagonists vii |
06/05/2003 | WO2003045913A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use |
06/05/2003 | WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
06/05/2003 | WO2003045878A2 2,w-diaminocarboxylic acid compounds |
06/05/2003 | US20030105329 Process for the production of piperidine derivatives |
06/05/2003 | US20030105161 Analgesics; antiinflamamtory agents |
06/05/2003 | US20030105134 Using diaroyltartaric acid as resolution agent; isomer purity; attention deficit disorders |
06/05/2003 | US20030105133 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists |
06/05/2003 | US20030105131 Aids therapy; antiinflamamtory agents; antiallergens; rheumatic diseases |
06/05/2003 | US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes |
06/05/2003 | US20030105079 Novel phenylalkyl diamine and amide analogs |
06/05/2003 | US20030105072 Compounds, compositions, and methods for controlling biofilms |
06/05/2003 | CA2468402A1 Ccr-3 receptor antagonists vii |
06/05/2003 | CA2467874A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor |
06/05/2003 | CA2467665A1 2,w-diaminocarboxylic acid compounds |
06/05/2003 | CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
06/05/2003 | CA2464107A1 Process for the synthesis of amine ethers from secondary amino oxides and uses |
06/04/2003 | EP1315701A1 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
06/04/2003 | EP1315700A2 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine |
06/04/2003 | EP1315495A2 Use of threo-methylphenidate compounds to enhance memory |
06/04/2003 | EP1315493A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
06/04/2003 | EP1165543B1 PROCESS FOR PREPARING S-(R*,S*)] -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES |
06/04/2003 | EP1131289A4 Processes for preparing 2-piperidineethanol compounds |
06/04/2003 | EP1114027B1 The preparation of n-substituted-hydroxycycloalkylamine derivatives |
06/04/2003 | EP1062358B1 Novel method for preparing fexofenadine |
06/04/2003 | EP1017395A4 Method for treating premenstrual or late luteal phase syndrome |
06/04/2003 | EP0863875B1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
06/04/2003 | EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase |
06/04/2003 | EP0819120B1 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
06/04/2003 | EP0804417B1 Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents |
06/04/2003 | CN1422156A Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections |
06/04/2003 | CN1421434A Prepn process of nifedipine |
06/04/2003 | CN1110497C Di-or triaza-spiral [4,5] decane derivative |
06/04/2003 | CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
06/04/2003 | CN1110479C Production of 1-chlorocarbonyl-4-piperidinopieridine or hydrochloride thereof |
06/04/2003 | CN1110478C Biocidal benzylbiphenyl derivatives |
06/03/2003 | US6573384 Process for production of indole derivatives and intermediates therefor |
06/03/2003 | US6573346 Telechelics based on vinyl polymers using a functionalized alkoxyamine initiator |
06/03/2003 | US6573281 Its pharmaceutically acceptable salts for the treatment or prevention of adaptation disorders, bipolar disorders, and dysthymic disorders. |
05/30/2003 | WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
05/30/2003 | WO2003044012A1 N-formyl derivatives of paroxetine |
05/30/2003 | WO2003043989A1 Hydrophilic (s)-amlodipine salts or their hydrates and pharmaceutical compositions |
05/30/2003 | WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
05/30/2003 | WO2003043987A2 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
05/30/2003 | WO2003043975A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
05/30/2003 | WO2003043635A1 Amlodipine salt forms and processes for preparing them |
05/30/2003 | WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease |
05/30/2003 | WO2002062885A3 Polymeric articles containing hindered amine light stabilizers based on multi-functional carbonyl compounds |
05/30/2003 | WO2002031025A9 Biodegradable poly(beta-amino esters) and uses thereof |
05/30/2003 | CA2467798A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
05/30/2003 | CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient |
05/30/2003 | CA2467749A1 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
05/30/2003 | CA2467476A1 Amino diols useful in the treatment of alzheimer's disease |
05/30/2003 | CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
05/30/2003 | CA2464327A1 N-formyl derivatives of paroxetine |
05/29/2003 | US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
05/29/2003 | US20030100750 Process for solid supported synthesis of pyruvate-derived compounds |
05/29/2003 | US20030100681 Crosslinkable monomers for novel nonlinear optical polymers |
05/29/2003 | US20030100561 Treatment of insulin resistance with growth hormone secretagogues |
05/29/2003 | US20030100547 Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies |
05/29/2003 | US20030100532 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
05/29/2003 | US20030100494 Containing growth hormone secretion promoting substance for prophylaxis and therapy of diseases involving degeneration or death of nerve cells |
05/29/2003 | US20030100018 Mass-based encoding and qualitative analysis of combinatorial libraries |
05/28/2003 | EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
05/28/2003 | EP1313703A1 Prodrugs to nmda receptor ligands |
05/28/2003 | EP1313700A1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds |
05/28/2003 | EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
05/28/2003 | EP1313477A1 Compounds and methods |
05/28/2003 | EP1163239B1 Modified amino-acid amides as cgrp antagonists |
05/28/2003 | EP0971713B1 Use of cholinesterase inhibitors to treat disorders of attention |
05/28/2003 | CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha |
05/28/2003 | CN1420871A 4-formyl amino-N- methylpiperidine derivs., use thereof as stabilisers and organic material stabilised therewith |
05/28/2003 | CN1420870A Modulators of dopamine neurotransmission |
05/28/2003 | CN1420869A Modulators of dopamine neurotransmission |
05/27/2003 | US6570038 Aqueous hexasubstituted guanidinium chlorides and methods for their preparation and use |
05/27/2003 | US6570018 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor |
05/27/2003 | US6569861 Melanin concentrating hormone receptor ligands |
05/27/2003 | US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity |
05/27/2003 | US6569849 N-Substituted azaheterocyclic compounds |
05/27/2003 | CA2268847C Substituted oximes derivatives useful as neurokinin antagonists |
05/22/2003 | WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
05/22/2003 | WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |